Department of Surgery, Duke University Medical Center, Durham, NC, USA.
Department of Pathology, Duke University, Durham, NC, USA.
Transpl Int. 2021 Mar;34(3):572-584. doi: 10.1111/tri.13820. Epub 2021 Feb 9.
Vascularized composite allotransplants (VCAs) seem to have several unique features of clinical and experimental importance, including uniquely definable lymphatic drainage that can be easily accessed at the level of ipsilateral regional node beds. Thus, VCA offers a unique opportunity to assess the relative contribution of peripheral and secondary lymphoid tissue to the process of rejection. We transplanted hind limb grafts from C3H donors to six different groups of C57BL/6 recipients: Spleen Map3k14 ; Spleen Map3k14 ; Spleen Node Map3k14 ; and Spleen Node Map3k14 . As positive controls, we used Map3k14 with or without spleen. Map3k14 mice demonstrated an average graft survival of 9.6 and 9.2 days for Spleen and Spleen Map3k14 , respectively. Rejection in the Map3k14 group was considerably delayed (28.4 days, P = 0.002) in all recipients. The Spleen Map3k14 mice rejected their hind limb allografts in an even more delayed fashion compared to Spleen Map3k14 (54.4 days, P = 0.02). Histological analysis of skin showed that acute rejection in both Map3k14 mice groups was graded as Banff III or Banff IV. In the Map3k14 groups, rejection was graded as Banff III. We demonstrated that in the absence of lymph nodes, grafts reject in a delayed fashion. Also, splenectomy in alymphoplastic mice further extends graft survival, but does not eliminate rejection all together.
血管化复合组织同种异体移植(VCAs)似乎具有一些独特的临床和实验特征,包括独特的可定义的淋巴引流,可以在同侧区域淋巴结床水平上轻松触及。因此,VCA 为评估外周和次级淋巴组织对排斥反应过程的相对贡献提供了独特的机会。我们将 C3H 供体的后肢移植物移植到六组不同的 C57BL/6 受体中:脾 Map3k14 ;脾 Map3k14 ;脾节点 Map3k14 ;和脾节点 Map3k14 。作为阳性对照,我们使用了有或没有脾脏的 Map3k14。Map3k14 小鼠的脾脏和脾 Map3k14 分别平均移植物存活 9.6 和 9.2 天。在所有受体中,Map3k14 组的排斥反应明显延迟(28.4 天,P=0.002)。与脾 Map3k14 相比,脾 Map3k14 小鼠的后肢同种异体移植物排斥更加延迟(54.4 天,P=0.02)。皮肤的组织学分析表明,两组 Map3k14 小鼠的急性排斥反应均被评为 Banff III 或 Banff IV。在 Map3k14 组中,排斥反应被评为 Banff III。我们证明,在没有淋巴结的情况下,移植物会延迟排斥。此外,在无淋巴组织的小鼠中进行脾切除术可进一步延长移植物的存活时间,但并不能完全消除排斥反应。